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Abstract  
Objective: To determine whether selected metabolic factors are associated with greater amounts of 
radiographic hand osteoarthritis (OA) incidence and progression. 
Methods: 706 adults, aged 50-69 years with hand pain and hand radiographs at baseline, were identified 
from two population-based cohorts. Metabolic factors (body mass index, hypertension, dyslipidaemia, and 
diabetes) were ascertained at baseline by direct measurement and medical records. Analyses were 
undertaken following multiple imputation of missing data, and in complete cases (sensitivity analyses). 
Multivariable regression models estimated associations between metabolic factors and two measures of 
radiographic change at 7-years for all participants, individuals free of baseline radiographic OA and in 
baseline hand OA subsets. Estimates were adjusted for baseline values and other covariates.  
Results: The most consistent and strong associations observed were between the presence of diabetes and 
the amount of radiographic progression in individuals with nodal OA (adjusted mean differences in KLsum 
score of 4.50 (-0.26, 9.25)), generalised OA (3.27 (-2.89, 9.42)), and erosive OA (3.05 (-13.56, 19.67)). The 
remaining associations were generally weak or inconsistent, although numbers were limited for analyses of 
incident radiographic OA and erosive OA in particular. 
Conclusion: Overall metabolic risk factors were not independently or collectively associated with greater 
amounts of radiographic hand OA incidence or progression over 7-years, but diabetes was associated with 
radiographic progression in nodal, and possibly generalised and erosive OA. Diabetes has previously been 
associated with prevalent but not incident hand OA, further investigation in hand OA subsets using 
objective measures accounting for disease duration and control is warranted.  
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Introduction 
Symptomatic hand osteoarthritis (OA) is estimated to affect 8.2% of men and 15.9% of women in the 
general population (1). The course of hand OA is not clear but is thought to be heterogeneous with some 
individuals experiencing substantial deterioration in structure, pain, and function while others remain 
stable for many years (2). Currently, there is limited evidence regarding the risk factors for hand OA 
progression (3), and the need to gain further understanding of the aetiology and course of hand OA has 
been highlighted as a research priority (4). 
 
Metabolic factors have been associated with hand OA but mainly in cross-sectional studies, systematic 
reviews have reported associations of obesity and type 2 diabetes with hand OA (5,6), and additional 
studies have reported associations between metabolic syndrome and hand OA (7-9). These findings suggest 
systemic metabolic disturbances may play a role in the pathophysiology of hand OA. As the hands are not 
exposed to the joint loading effects of obesity, they are an ideal site to investigate associations between 
metabolic factors and OA.  
 
However, the role metabolic factors play in the incidence and progression of hand OA is unclear, as little 
longitudinal research has been undertaken. Apart from one study that did not find an association between 
type 2 diabetes and incident hand OA (10), and two studies that examined hyperlipidaemia and incident 
hand OA with differing results (11,12) most studies have focused on obesity, and conflicting findings have 
been reported (13-22). The disparity in results could be due to variations in study populations and the 
definitions of progression used. However, the relationship between obesity and hand OA progression could 
be confounded or mediated by the presence of hypertension, dyslipidaemia and diabetes and to date, and 
few analyses have examined metabolic factors independently from each other. Furthermore, the impact of 
multiple metabolic factors on the course of hand OA has been examined but only in a single study where no 
association was found between metabolic syndrome and incident and progressive hand OA (23).  
 
There is some evidence that the role of metabolic factors in hand OA pathogenesis varies between subsets 
of hand OA. Obesity, hypertension, dyslipidaemia and metabolic syndrome occurred more often in 
community-dwelling individuals with erosive OA compared to other subsets (24). Also, significantly 
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elevated levels of a serum adipokine adiponectin, which have been associated with obesity, have been 
found in erosive OA compared to patients with non-erosive hand OA and healthy controls (25). The 
association between atherosclerosis and hand OA progression was noted to differ by joint group (26). 
Therefore, the conflicting findings previously reported between obesity and hand OA incidence and 
progression could also be explained by differing proportions of hand OA subsets within the study 
populations. 
 
This study sought to determine in population-based older adults whether obesity, diabetes, hypertension 
and dyslipidaemia and the accumulation of metabolic factors are independently associated with 
radiographic hand OA incidence and the progression over 7-years as well as progression within different 
baseline subsets of hand OA. 
 
 
Materials and methods 
Study population & design 
Study participants were from a population-based prospective cohort, the Clinical Assessment Studies of the 
Hand (CASHA)(27). At baseline all adults aged ≥50 years registered with two general practices in North 
Staffordshire, UK were invited to participate in a two-stage survey. In the UK, 95% of people are registered 
with general practices thus providing convenient general population sampling frames. Those reporting 
hand pain or problems in the last year were invited to attend research clinics that included radiographs and 
assessment of finger nodes in the 2nd and 3rd interphalangeal (IP) joints of each hand by trained assessors. 
To increase the numbers in each hand OA subset, the sample was enriched with participants from the 
Clinical Assessment Studies of the Knee (CASK)(28) who were recruited using an identically performed two-
stage survey in a similar population of three general practices in the same locality of North Staffordshire. 
Individuals in this study who reported knee pain in the previous year were invited to attend research clinics, 
where they also received an identical hand radiographs and assessment of finger nodes to CASHA 
participants.  
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All participants included in the current analyses were aged 50-69 years at baseline, had reported hand pain 
on few days or more in the previous month (29), had hand radiographs, and did not have inflammatory 
arthritis (n=764). Follow-up was at approximately 7-years with a postal questionnaire and research clinic 
including hand radiographs. An Index of Multiple Deprivation (IMD)(30), based on a combination of 
education, employment, income, health, and crime figures in English neighbourhoods, was obtained for 
each participant using their postcode. UK Local Research Ethics Committees approved these studies (LREC 
Project No’s: 1430, 05/Q2604/72, 06/Q2801/90). All participants provided written informed consent. 
 
Radiographic assessment 
Posterior-anterior hand radiographs were taken according to a standardised protocol (27,28). Two trained 
readers scored twenty hand joints (distal, proximal and thumb IPs and 1st carpometacarpal (1CMC)) for OA 
using the Kellgren and Lawrence (KL) grading system (0-4) at baseline and 7-years unpaired but with known 
chronological order (31). A single reader scored the presence of erosive OA using the Verbruggen-Veys 
Anatomical Phase Progression Score in sixteen IP joints at each time-point (32). Reliability has previously 
been reported for the presence of OA and erosive OA at baseline (24). At 7-years intra-rater reliability was 
substantial for OA (unweighted Kappa (Ku)=0.88 & 0.67, percentage agreement (PA)=96% & 93%) and 
erosive OA (Ku=0.89, PA=99%), and inter-rater reliability was moderate for OA (Ku=0.64, PA=91%) and 
substantial for erosive OA (Ku=0.84, PA=98%).  
 
Hand OA subsets  
The hand OA subsets examined and their definitions were: thumb base OA (KL≥2 in the 1CMCJ in either 
hand); nodal IPJ OA (KL≥2 in ≥2 IPJs (rays 2-5) & ≥2 nodes (rays 2-3) across either hand); generalised hand 
OA (KL≥2 in ≥1 distal IPJ & ≥1 proximal IPJ & ≥1 1CMCJ across either hand); and erosive OA (E- or R-phase of 
the Verbruggen-Veys Anatomical Phase Progression Score in ≥2 IPJ (rays 2-5) across either hand)(24).  
 
Radiographic change 
The amount of radiographic change was assessed by two outcomes using continuous measures to avoid 
loss of information and inflation of type 2 errors (13,25,33,34): 
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i) the KL summed (KLsum) score for 20 hand joints at 7-years (0-80) adjusted for the baseline KLsum 
score (0-80)(providing a composite measure of change that combines the amount of within-joint 
change and the number of joints changing) 
ii) the number of joints with KL≥2 at 7-years (0-20) adjusted for baseline number of joints with KL≥2 (0-
20)(change represents the number of joints newly classed as having definite radiographic disease)  
 
Incident radiographic OA was investigated in participants free of radiographic OA (KL<2) at baseline 
whereas the term progression was used to collectively refer to radiographic worsening in participants with 
and without baseline radiographic OA. 
 
Participants with maximum scores at baseline were excluded from analyses, as they could not undergo 
further progression. 
 
Risk factors 
Metabolic risk factors included body mass index (BMI), determined from height and weight measured at 
the baseline research clinics and used as a continuous variable. Consultations and/or diagnoses of 
hypertension, dyslipidaemia and type 2 diabetes/impaired fasting glucose (IFG) in the 2 years before and 2 
years after the baseline research clinics were obtained from primary care medical records for those 
participants providing permission (94%, n=660) and used as dichotomous variables. Consultations and 
diagnoses in the UK are coded using a hierarchical method of standardised Read Codes (35). The validity of 
using the Read Codes for type 2 diabetes and hypertension was examined against individuals self-reporting 
having diabetes and raised blood pressure and was found to be 95% and 87% respectively. The validity of 
having a Read Code for type 2 diabetes was further checked against prescriptions records. All individuals 
prescribed a diabetic drug in the 2 years before and after baseline had a Read Code for diabetes in the 
same period.  
 
The collective influence of multiple metabolic factors was examined using the number of metabolic risk 
factors (0-4), and the presence of metabolic syndrome (adapted from the NCEP/ATPIII definition)(36), 
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which was classed as three or more of the following: BMI ≥30, hypertension, dyslipidaemia and diabetes 
type 2/IFG.  
 
Statistical analysis 
Descriptive characteristics for all baseline participants, those followed-up at 7-years by postal questionnaire 
and at the 7-year research clinics were compared.  
 
Baseline scores were plotted against 7-year scores to investigate the amount of radiographic change for the 
two outcomes, stratified by sex. Adjusted mean estimates and 95%CIs were determined at 7-years for both 
outcomes using analysis of covariance. Analyses were stratified by sex and adjusted for baseline value of 
the outcome, cohort (CASK or CASHA), age, and time to follow-up.  
 
The independent associations between metabolic factors and incidence and progression of radiographic 
hand OA at 7-years were estimated using analysis of covariance (KLsum, number of joints) using three 
models: 1) BMI, hypertension, dyslipidaemia, diabetes type 2/IFG; 2) metabolic syndrome; 3) number of 
metabolic factors. All models were adjusted for the following potential confounders: baseline radiographic 
score, sex, baseline age, cohort, time to follow-up, baseline smoking status (never, ex, current) and IMD. 
This analysis was undertaken in all study participants, stratified by baseline hand OA subset and in those 
with no baseline hand OA (KL≤2). 
 
Analyses that exclude individuals with missing data are acknowledged to produce biased estimates and 
reduced power and precision compared to those including all individuals (37,38). Multiple Imputation (MI) 
is recognised as an appropriate statistical method for handling missing data and overcoming the 
aforementioned limitations through addressing the uncertainty around missing values by generating 
imputes in multiple datasets (39). Therefore MI was undertaken using chained equations (MICE) in all 
eligible individuals. Primary analyses were undertaken in the imputed datasets, with complete cases 
analyses undertaken for sensitivity purposes (40). Data were imputed for missing 7-year outcome scores 
(45.0%) and for missing baseline data (BMI 0.3%; Index of Multiple Deprivation 0.3%; baseline smoking 
status 1.3% and metabolic factors 6.5% in those not consenting to medical record review). Fifty imputed 
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datasets were generated (41,42). A relatively large amount of outcome data was imputed, but research has 
shown that models still perform well in these situations (39,43-45). The distribution of variables in the 
imputed datasets were checked ensuring plausible values had been imputed, and model assumptions were 
verified. MI relies on variables being missing completely at random or missing at random (37,46). Missing 
data were associated with a number of baseline variables and therefore assumed to be missing at random. 
The imputation model included these baseline variables as well as the metabolic factors and 7-year 
outcomes to increase the power and precision of the imputation model (Supplementary Table 1)(47). Data 
could still be missing due to other unaccounted variables, but our participants were well-characterised with 
an extensive range of descriptive, sociodemographic, hand symptoms, general, physical and mental health, 
and self-reported comorbidities. Rubin’s rules were used to combine estimates from imputed datasets (48). 
Analyses were performed using SPSS v21.0 (IBM Corporation, Armonk, NY, USA).  
 
 
Results 
Study population 
Of 764 eligible individuals at baseline, after 58 exclusions (deaths or untraced departures from GP practice 
(31), severe ill health or terminal illness (21), address unknown (6)), 552 of the 706 were followed up at 7-
years (adjusted response 78%)(Figure 1). Those lost to follow-up were mainly due to failure to renew 
consent to further contact at the interim 3-year follow-up (105). Some respondents at 7-years were 
unwilling to attend the 7-year research clinic (157); therefore a total of 388 had hand radiographs at 
baseline and follow-up with a mean follow-up time of 83 months (SD 6.7).  
 
Compared with all eligible participants at baseline, those followed up with hand radiographs at 7-years 
were less likely to be a current or ex-smoker, have type 2 diabetes/IFG, and had slightly lower anxiety & 
depression scores. The distribution of other baseline variables was similar (Table 1).  
 
One individual was excluded from the analyses examining the progression of the number of hand joints 
with KL≥2 due to having the maximum number of 20 joints affected at baseline, where applicable this is 
indicated in the relevant results tables.  
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Radiographic change 
Scatterplots indicate positive linear trends between the baseline and 7-year scores for both hand OA 
outcomes in the imputed data and were similar for men and women (Figure 2). Overall, in the imputed data 
the amount of radiographic change at 7 years was significantly lower in men compared to women for each 
outcome (Table 2). Compared to the overall estimates of radiographic change at 7-years, those who were 
free of radiographic OA at baseline on average underwent less change, whereas those who had thumb 
base, nodal, generalised and erosive OA at baseline experienced more change (Table 2). Results were 
comparable in the complete case analysis although the amount of radiographic change was slightly lower 
for the no baseline hand OA group (Supplementary Figure 1, Supplementary Table 2). 
 
Association between metabolic factors and hand OA progression 
Overall in all participants, generally non-significant weak associations were found between each of the 
metabolic factors and the amount of radiographic change for both of the outcomes at 7-years, with 
adjusted mean differences over 7-years of less than 1 point for the KLsum score or 1 joint affected with OA 
(Table 3). These findings were replicated in the complete case analysis (Table 3). 
 
Association between metabolic factors and progression in hand OA subsets 
For the nodal, generalised and erosive hand OA subsets adjusted mean differences in the KLsum score at 7-
years were consistently higher in individuals with diabetes type 2/IFG compared to those without 
diabetes/IFG in the imputed data with the adjusted mean differences ranging from 3.05 (-13.56, 19.67) for 
erosive OA to 4.50 (-0.26, 9.25) for nodal IPJ OA (Table 3). In individuals with nodal OA, the number of 
affected hand joints at 7 years was also greater in those with diabetes/IFG compared to those without 
diabetes/IFG (adjusted mean difference 2.06 (0.25, 3.87) (Table 3). Results for erosive OA were similar, 
although estimates were much less precise due to the small number in this subset.  
 
The complete case analysis showed similar results but additionally, dyslipidaemia was positively associated 
with higher KL summed score and an increase in hand joints affected with KL≥2 at 7-years in those with 
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thumb base OA, nodal OA and generalised OA, although this association was statistically significant only for 
the number of joints affected in thumb base OA (Table 3). 
 
Association between metabolic factors and incident hand OA  
In those free of radiographic OA at baseline, weak non-significant associations were found between the 
metabolic factors and the amount of radiographic change for the two outcomes at 7-years, adjusted for 
baseline score and other potential confounders (Table 4). Findings were comparable in the complete case 
analysis (Table 4).  
 
 
Discussion 
Adjusted for baseline values and other covariates the amount of radiographic change for each outcome at 
7-years varied by gender and by baseline hand OA subset, with females and those with nodal, generalised 
and erosive OA undergoing greater amounts of progression. Overall, obesity, hypertension, dyslipidaemia 
and diabetes type 2/IFG, were not found to be associated, either independently or collectively, with the 
amount of radiographic incidence or progression over 7-years in people with hand symptoms. Trends in the 
data indicated that the association between metabolic factors and progression might vary by hand OA 
subset. Diabetes was associated with greater amounts of radiographic progression in those with nodal OA 
at baseline and possibly implicated in those with generalised and erosive OA.  
 
In this population-based prospective cohort study, descriptive analysis of individuals followed-up with hand 
radiographs at 7-years compared to those lost to follow-up suggest the possibility of attrition bias. As 
missing data from loss to follow-up could have affected estimates of the associations between metabolic 
factors and incidence and progression of radiographic hand OA, MI was undertaken for missing data 
(37,46). Therefore, discrepancies between the results of the complete case analysis and the imputed data 
are likely to be due to selective loss to follow-up, as was noted in the differences in baseline characteristics, 
and estimates obtained in the MI data given more credence.  
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A meta-analysis of cross-sectional studies found an association between the presence of diabetes and OA 
(6). Hyperglycaemia has been associated with elevated reactive oxygen species and advanced glycation end 
products that are thought to lead to low-grade inflammation and oxidative stress, which is believed to 
damage the chondrocytes (49). We believe this is the first study to examine diabetes as a risk factor for 
hand OA progression, and find an association in nodal OA. There were also non-significant patterns for 
increased progression in generalised and erosive OA, though this could be due to the small numbers in the 
erosive and generalised OA subsets affecting the precision of the estimates. The consistently higher mean 
differences in the KLsum score at 7-years of between 3 and 5 points in individuals with diabetes compared 
to those without suggests that diabetes may contribute to progression in specific hand OA subsets, 
particularly nodal OA. Further examination of the effects of diabetes and the other metabolic risk factors on 
hand OA progression across different hand OA subsets is required.  
 
While inconsistent findings have been reported in the relation between obesity and hand OA progression 
(15-17), these early studies were at risk of collider bias due to conditioning on the presence of baseline 
radiographic hand OA (13,50,51). Restricting participants to only those with existing hand OA, could lead to 
biased estimates of the relationship between potential risk factors and hand OA progression. The weak 
non-significant association between BMI and hand OA progression in the current study is consistent with 
the results of the Oslo Hand OA Cohort (13). These concordant findings were despite differences in the 
study population settings (primary versus secondary care), the severity of hand OA at baseline (mean 
baseline KLsum score 7.8 versus 21.0 respectively) and adjustment for the presence of other metabolic 
factors in the current study. Risk factors for hand OA could vary for different stages of disease (52) as 
associations have been reported between obesity and diabetes, and incident hand OA (10,18-21), but the 
current work did not find an association between obesity or diabetes and incident OA over 7-years. This 
lack of association could be due to the relatively small numbers available in the incident analyses, the small 
amounts of change that were seen in KLsum score and number of joints with KL≥2 over 7-years in this 
group and because while individuals were free of radiographic OA, they had hand pain and could have had 
clinical or pre-radiographic OA. 
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The lack of association between metabolic factors and the amount of hand OA progression does not 
necessarily mean that no association exists. The presence of an association is likely to be affected by the 
time it takes for an exposure to affect the structure of a joint and the amount of exposure that is required 
to induce change.  
 
This study used a large well-characterised cohort through which selective loss to follow-up was determined 
and overcome using MI. Attempts were also made to overcome collider bias, which is thought to have been 
a limitation of previous research (15-17), by including all participants in the analysis, so there was no 
conditioning for the presence of existing radiographic hand OA, an approach taken by others (13,53). 
Associations between metabolic factors and radiographic change were also examined in the subgroup of 
individuals who were free of OA at baseline, but the findings were unchanged. We, therefore, accept there 
is a risk of collider bias if the aim is to estimate the total effect of metabolic factors (the pre-baseline and 
the baseline status) on disease incidence and progression. However, we feel our study still makes a useful 
contribution as our findings highlight that it is unlikely that the change in radiographic OA between baseline 
and 7-years would be affected by the status of metabolic factors at baseline in a population of mid to later 
adulthood. Of course, it is still possible that the prevention of these metabolic risk factors would have some 
effect on radiographic OA change. 
 
There are some limitations that should be acknowledged. Participants were from two studies, but both 
were general population samples from the same locality, the same data collection was used, and follow-up 
rates were comparable. It was not possible to differentiate between recently diagnosed and long-standing 
exposures as we only had consent to access individuals’ medical records for the period 2 years prior and 
post baseline recruitment. Furthermore, objective exposure measurements could not be used as not all 
individuals had values entered in their medical records. More precise information might reveal differences 
in risk in those who are more severely affected compared to those individuals just above the threshold for 
diagnoses. Additionally, our analysis did not allow us to differentiate between the presence of a risk factor 
that is optimally managed and those that are not, which could affect the relation between metabolic 
factors and hand OA incidence and progression. Finally, while the presence of nodes on rays 2 to 5 was 
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collected in the CASHA cohort, nodes were only determined on rays 2 and 3 in the CASK cohort to fulfil ACR 
criteria, which could have led to nodal incidence and progression being underestimated.  
 
Overall metabolic risk factors were not independently or collectively associated with greater amounts of 
radiographic hand OA incidence and progression over 7-years. Potential variation was found between the 
baseline hand OA subsets; with diabetes being a risk factor for radiographic hand OA progression in 
individuals with nodal, and possibly generalised and erosive OA. Further research is needed to explore 
differences between hand OA subsets, using objective measures to assess metabolic factors, taking account 
of the duration of exposures and to what extent metabolic factors are controlled.  
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Table 1. Characteristics of study participants overall, those followed-up at 7-years and those with hand 
radiographs at baseline and 7-years  
   
  
Baseline Characteristics 
Participants 
(n=706) 
Participants 
followed-up by 
questionnaire at 
7-years (n=522) 
Participants who 
attended research 
clinic and had hand 
radiographs at 7-
years (n=388) 
% Female (n) 62.0 (438) 60.9 (318) 60.1 (233) 
Age, mean (SD)  60.5 (5.2) 
) 
 
60.3 (5.3) 60.5 (5.2) 
% CASHA Study (n) 51.4 (363) 54.6 (285) 51.5 (200) 
Index of multiple deprivation, mean (SD) 14971 (7425) 15524 (7390) 15316 (7509) 
% White ethnicity (n) 99.7 (693) 99.8 (512) 99.7 (381) 
% Smoking (n) 
 
   
Never 48.4 (338) 51.8 (268) 54.4 (210) 
Ex 
 
41.4 (289) 
 
39.7 (205) 38.6 (149) 
Current 10.2 (71) 8.5 (44) 7.0 (27) 
% Hand pain on most or all days in the last month (n) 44.7 (315) 44.4 (232) 45.4 (176) 
AUSCAN pain, mean (SD) 6.7 (4.2) 6.5 (4.1) 6.5 (4.1) 
AUSCAN function, mean (SD) 10.0 (8.1) 9.6 (7.9) 9.6 (7.9) 
AUSCAN stiffness, mean (SD) 1.2 (1.0) 1.2 (1.0) 1.2 (0.9) 
% Radiographic hand OA (KL≥2 in ≥1 joints) (n) 68.7 (485) 68.1 (356) 67.5 (262) 
Baseline summed KL score (0-80), mean (SD) 
   median (IQR) 
8.2 (9.6) 
5 (2, 11) 
7.9 (9.2) 7.8 (9.1) 
Baseline number of joints KL≥2 (0-20), mean (SD) 
   median (IQR) 
2.8 (3.4) 
2 (0, 4) 
2.7 (3.3) 
2 (0, 4) 
2.7 (3.3) 
2 (0, 4) 
% Thumb base OA (KL≥2 in either 1CMCJ) (n) 42.9 (303) 43.1 (225) 43.6 (169) 
% Nodal IPJ OA (KL≥2 in ≥2 IPJs (rays 2-5) & ≥2 nodes (rays 2-3) 
across either hand) (n) 
21.5 (152) 21.3 (111) 21.9 (85) 
% Generalised hand OA (KL≥2 in ≥1 distal IPJ & ≥1 proximal IPJ 
& ≥1 1CMCJ across either hand) (n) 
11.8 (83) 10.9 (57) 11.6 (45) 
% Erosive OA (E or R phase in ≥2 IPJ (rays 2-5) across either 
hand) (n) 
3.1 (22) 3.3 (17) 2.8 (11) 
Metabolic factors    
   BMI, mean (SD) 29.2 (5.2) 28.9 (4.9) 28.9 (4.9) 
   % Hypertension (n) 36.4 (240) 36.7 (180) 36.6 (234) 
   % Diabetes type 2 or impaired fasting glucose (n) 10.8 (71) 8.6 (42) 9.8 (36) 
   % Dyslipidaemia (n) 30.8 (203) 31.4 (154) 31.2 (115) 
   No. metabolic factors, mean (SD) 
      median (IQR) 
1.1 (1.0) 
1 (0, 2) 
1.1 (1.0) 1.1 (1.1) 
   % Metabolic Syndrome (n) 11.2 (74) 10.0 (49) 11.4 (42) 
SF12 Physical Component Score, mean (SD) 39.2 (12.1) 39.9 (11.9) 40.0 (12.0) 
SF12 Mental Component Score, mean (SD) 49.9 (11.0) 50.8 (10.6) 51.1 (10.6) 
HADS Anxiety scale, mean (SD) 7.2 (4.2) 6.8 (4.1) 6.6 (4.1) 
HADS Depression scale, mean (SD) 4.7 (3.6) 4.4 (3.5) 4.3 (3.4) 
SF36 Physical functioning scale, mean (SD) 60.6 (28.4) 63.0 (27.8) 62.6 (28.3) 
SD, Standard deviation; AUSCAN, Australian Canadian Hand Osteoarthritis Index; KL, Kellgren Lawrence; IPJ, Interphalangeal Joint; 1CMC, First 
Carpometacarpal joint; BMI, Body Mass Index 
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Table 2. The amount of radiographic change at 7-years overall, for those free of radiographic OA at baseline, and 
also separately for baseline hand OA subsets, stratified by sex in the imputed data (n=706) 
 Females    Males  
 Outcome = Kellgren-Lawrence summed score (0-80) 
 
n 
Adjusted 
mean* 
(95%CI)  n 
Adjusted 
mean* 
(95%CI) 
Total 438 17.0 (15.8, 18.2)  268 12.5 (11.2, 13.8) 
No baseline hand OA  123 9.0 (7.1, 10.9)  98 6.8 (4.7, 8.8) 
Thumb base OA 199 21.0 (19.6, 22.5)  104 16.1 (14.0, 18.1) 
Nodal IPJ OA 115 26.6 (23.6, 29.5)  37 21.5 (17.7, 25.4) 
Generalised hand OA 61 31.6  (28.0, 35.2)  22 27.6 (21.5, 33.7) 
Erosive OA 19 40.1 (34.9, 45.3)  3 - - 
 Outcome = Number of hand joints with Kellgren-Lawrence Grade≥2 (0-20) † 
 n Adjusted 
mean* (95%CI) 
 
n 
Adjusted 
mean* (95%CI) 
Total 437 6.7 (6.2, 7.2)  268 5.3 (4.7, 5.8) 
No baseline hand OA  123 3.6 (2.9, 4.4)  98 2.8 (2.0, 3.7) 
Thumb base OA 198 8.2 (7.7, 8.8)  104 6.6 (5.8, 7.4) 
Nodal IPJ OA 114 10.5 (9.3, 11.7)  37 9.4 (7.9, 11.0) 
Generalised hand OA 60 12.1 (10.7, 13.4)  22 10.8 (8.9, 12.8) 
Erosive OA 18 13.5 (11.6, 15.4)  3 - - 
95% CI, 95% Confidence interval; * adjusted for baseline value of outcome measure, cohort, age, time to follow-up; † One individual 
excluded due to maximum number of joints affected at baseline (n=20); - unable to calculate due to small numbers. 
No hand OA = KL<2 in all hand joints; Nodal IPJ OA = KL≥2 in ≥2 IPJs (rays 2-5) & ≥2 nodes (rays 2-3) across either hand; Thumb base OA = 
KL≥2 in the 1CMCJ in either hand; Generalised hand OA = KL≥2 in ≥1 distal IPJ & ≥1 proximal IPJ & ≥1 1CMCJ across either hand; Erosive 
OA (≥2 IPJ (rays 2-5)) across either hand. 
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Table 3. The association between baseline metabolic factors and hand OA progression at 7-years for all participants 
and stratified by baseline hand OA subset  
 ANALYSIS BASED ON MULTIPLY IMPUTED DATA 
 
All participants 
(n=706) 
Thumb base OA 
(n=303) 
Nodal IPJ OA 
(n=152) 
Generalised OA 
(n=83) 
Erosive OA  
(n=22) 
 Outcome = Kellgren-Lawrence summed score (0-80) 
 Adjusted mean difference (95%CI)* 
BMI, kg/m
2
 † 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
-0.01 (-0.15, 0.13) 
0.45 (-1.12, 2.03) 
0.76 (-1.62, 3.13) 
0.07 (-1.51, 1.66) 
-0.11 (-0.33, 0.10) 
0.33 (-2.13, 2.78) 
1.50 (-1.75, 4.75) 
0.72 (-1.61, 3.04) 
-0.10 (-0.40, 0.20) 
1.82 (-1.59, 5.24) 
4.50 (-0.26, 9.25) 
1.40 (-2.09, 4.89) 
-0.37 (-0.87, 0.13) 
-0.36 (-6.04, 5.32) 
3.27 (-2.89, 9.42) 
1.81 (-3.83, 7.45) 
-0.47 (-2.13, 1.19) 
2.49 (-9.26, 14.24) 
3.05 (-13.56, 19.67) 
-6.55 (-19.58, 6.47) 
No. of metabolic factors 
(0-4) † 
0.02 (-0.57, 0.62) 0.06 (-0.81, 0.93) 0.75 (-0.72, 2.22) -0.46 (-2.54, 1.62) -2.09 (-7.94, 3.77) 
Metabolic syndrome ‡ 0.50 (-1.39, 2.40) 0.87 (-1.90, 3.64) 1.97 (-2.61, 6.54) -0.81 (-7.85, 6.23) -0.88 (-17.21, 15.44) 
 Outcome = Number of hand joints with Kellgren-Lawrence Grade≥2 (0-20) § 
 Adjusted mean difference (95%CI)* 
BMI, kg/m
2
† 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.01 (-0.05, 0.06) 
-0.01 (-0.63, 0.60) 
0.35 (-0.58, 1.28) 
0.21 (-0.41, 0.83) 
-0.05 (-0.13, 0.03) 
-0.12 (-1.04, 0.80) 
0.67 (-0.58, 1.93) 
0.53 (-0.36, 1.41) 
 0.01 (-0.11, 0.12) 
0.34 (-0.92, 1.61) 
2.06 (0.25, 3.87) 
0.67 (-0.60, 1.95) 
-0.11 (-0.29, 0.06) 
-0.61 (-2.59, 1.36) 
1.42 (-0.71, 3.56) 
1.09 (-0.89, 3.08) 
-0.15 (-0.87, 0.57) 
0.34 (-4.58, 5.25) 
2.02 (-6.02, 10.07) 
-1.02 (-5.65, 3.62) 
No. of metabolic factors 
(0-4) † 
-0.01 (-0.25, 0.25) 0.02 (-0.31, 0.35) 0.41 (-0.15, 0.98) -0.04 (-0.78, 0.70) -0.50 (-2.76, 1.77) 
Metabolic syndrome ‡ 0.42 (-0.37, 1.22) 0.68 (-0.38, 1.73) 1.70 (-0.09, 3.50) 0.47 (-1.99, 2.93) 0.25 (-6.05, 6.54) 
 COMPLETE CASE ANALYSIS 
 
All participants 
(n=365) 
Thumb base OA 
(n=169) 
Nodal IPJ OA     
(n=85) 
Generalised OA 
(n=45) 
Erosive OA       
(n=11) 
 Outcome = Kellgren-Lawrence summed score (0-80) 
 Adjusted mean difference (95%CI)* 
BMI, kg/m
2
 † 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.02 (-0.14, 0.19) 
0.80 (-0.85, 2.44) 
-0.25 (-2.91, 2.41) 
0.15 (-1.53, 1.83) 
-0.17 (-0.45, 0.11) 
0.38 (-2.57, 3.33) 
0.56 (-3.73, 4.84) 
1.59 (-1.29, 4.47) 
-0.14 (-0.55, 0.27) 
2.15 (-2.65, 6.94) 
7.78 (1.13, 14.43) 
2.34 (-2.56, 7.24) 
-0.92 (-2.00, 0.15) 
-4.5 (-15.24, 6.15) 
9.46 (-1.98, 20.90) 
4.93 (-4.98, 14.85) 
- 
- 
- 
- 
No. of metabolic factors 
(0-4) † 
0.10 (-0.61, 0.81) 0.08 (-1.02, 1.18) 1.49 (-0.46, 3.44) 0.01 (-3.83, 3.9) 1.12 (-4.59, 6.84) 
 
Metabolic syndrome ‡ 0.82 (-1.47, 3.11) 0.82 (-2.75, 4.39) 2.39 (-4.13, 8.92) -3.60 (-17.06, 9.87) 3.88 (-15.43, 23.18) 
 Outcome = Number of hand joints with Kellgren-Lawrence Grade≥2 (0-20) § 
 Adjusted mean difference (95%CI)* 
BMI, kg/m
2
† 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.01 (-0.06, 0.07) 
0.09 (-0.56, 0.75) 
-0.24 (-1.30, 0.83) 
0.27 (-0.40, 0.94) 
-0.08 (-0.17, 0.02) 
-0.28 (-1.31, 0.76) 
-0.20 (-1.70, 1.30) 
1.18 (0.16, 2.19) 
-0.01 (-0.15, 0.13) 
0.28 (-1.37, 1.92) 
3.35 (1.08, 5.62) 
1.27 (-0.41, 2.98) 
-0.25 (-0.55, 0.04) 
-2.08 (-4.97, 0.81) 
2.94 (-0.13, 6.00) 
2.44 (-0.33, 5.21) 
- 
- 
- 
- 
No. of metabolic factors 
(0-4) † 
-0.01 (-0.29, 0.28) 0.02 (-0.38, 0.42) 0.70 (-0.01, 1.39) 0.34 (-0.83, 1.50) 0.04 (-1.54, 1.62) 
Metabolic syndrome ‡ 0.41 (-0.50, 1.33) 0.39 (-0.90, 1.67) 2.19 (-0.09, 4.48) -0.29 (-4.36, 3.78) -1.02 (-5.04, 3.00) 
95% CI, 95% Confidence interval; BMI, Body Mass Index; IFG, Impaired Fasting Glucose; * estimated from analysis of covariance adjusted for 
baseline value of outcome measure, cohort, time to follow-up, sex, age, Index of Multiple Deprivation, smoking status; † per unit increase (all 
other factors are classed present/absent); ‡ Any three of BMI≥30kg/m
2
, diabetes type 2/IFG, hypertension, dyslipidaemia; § One individual 
excluded due to maximum number of joints affected at baseline; - unable to calculate due to small numbers. Thumb base OA = KL≥2 in the 
1CMCJ in either hand; Nodal IPJ OA = KL≥2 in ≥2 IPJs (rays 2-5) & ≥2 nodes (rays 2-3) across either hand; Generalised hand OA = KL≥2 in ≥1 distal 
IPJ & ≥1 proximal IPJ & ≥1 1CMCJ across either hand; Erosive OA = ≥2 IPJ (rays 2-5) across either hand. 
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Table 4. The association between baseline metabolic factors and incident hand OA 
at 7-years in those free of radiographic hand OA at baseline  
  ANALYSIS BASED ON MULTIPLY IMPUTED DATA 
 Participants free of hand OA at baseline (n=221) 
 Outcome = Kellgren-Lawrence summed score (0-80) 
 Adjusted mean difference* (95%CI) 
BMI, kg/m
2 
† 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.05 (-0.18, 0.28) 
-0.26 (-2.70, 2.18) 
0.66 (-3.25, 4.57) 
-0.22 (-2.83, 2.40) 
No. of metabolic factors (0-4) † -0.36 (-1.40, 0.68) 
Metabolic syndrome ‡ -0.15 (-3.53, 3.22) 
 Outcome = Number of hand joints with Kellgren-
Lawrence Grade≥2 (0-20) § 
 Adjusted mean difference* (95%CI) 
BMI, kg/m
2 
† 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.02 (-0.08, 0.12) 
-0.20 (-1.19, 0.79) 
0.04 (-1.48, 1.55) 
0.16 (-0.92, 1.23) 
No. of metabolic factors (0-4) † -0.15 (-0.59, 0.28) 
Metabolic syndrome ‡ -0.07 (-1.52, 1.39) 
 COMPLETE CASE ANALYSIS 
 Participants free of hand OA at baseline (n=126)  
 Outcome = Kellgren-Lawrence summed score (0-80) 
 Adjusted mean difference* (95%CI) 
BMI, kg/m
2 
† 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.10 (-0.12, 0.33) 
-0.34 (-2.45, 1.78) 
-0.25 (-3.78, 3.29) 
0.04 (-2.35, 2.43) 
No. of metabolic factors (0-4) † -0.16 (-1.13, 0.81) 
Metabolic syndrome ‡ -0.15 (-3.26, 2.96) 
 Outcome = Number of hand joints with Kellgren-
Lawrence Grade≥2 (0-20) § 
 Adjusted mean difference* (95%CI) 
BMI, kg/m
2 
† 
Hypertension 
Diabetes type 2/IFG 
Dyslipidaemia 
0.02 (-0.08, 0.11) 
-0.19 (-1.12, 0.74) 
-0.42 (-1.98, 1.13) 
0.08 (-0.98, 1.13) 
No. of metabolic factors (0-4) † -0.16 (-0.59, 0.27) 
Metabolic syndrome ‡ -0.11 (-1.47, 1.26) 
95% CI, 95% Confidence interval; BMI, Body Mass Index; IFG, Impaired Fasting Glucose; * estimated 
from analysis of covariance adjusted for baseline value of outcome measure, cohort, time to follow-up, 
sex, age, Index of Multiple Deprivation, smoking status; † per unit increase (all other factors are classed 
present/absent); ‡ Any three of BMI≥30kg/m
2
, diabetes type 2/IFG, hypertension, dyslipidaemia; § One 
individual excluded due to maximum number of joints affected at baseline. 
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Figure 1. Flow diagram of study participants 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
Consent withdrawn before 7-years (n=105) 
 Withdrawn consent before 3-year follow-up (34) 
 Responder at 3 years but no consent to further 
contact (45) 
 Non-response at 3 years (26) 
Did not attend research clinic at 7-years (n=157) 
 
 
No hand radiographs (n=7) 
 
 
Hand radiographs obtained at 7-years 
(n=388) 
 
 
Returned Postal Questionnaire at 7-years 
(n=522) 
Attended research clinic at 7-years 
 (n=395) 
Refusal /Non-response at 7-years (n=79) 
 Refusal (18) 
 Non-response (31) 
Invitation to take part in 7-year follow-up  
 (n=609) 
Excluded during 7-year mailing (n=8) 
 Deaths (3) 
 Severe ill health or terminal illness (3) 
 Address unknown (2) 
 
 
 
 
Excluded before 7-year mailing (n=50) 
 Deaths & untraced departures from GP 
practice (28) 
 Severe ill health or terminal illness (18)  
 Address unknown (4) 
 
 
 
 
Adults age 50-69 years who attended baseline 
research clinics  
(n=999) 
Hand pain in th last month on few days or 
more  
(n=819) 
Complete baseline radiographic data 
available 
(n=764) 
 
Excluded before analysis (n=55) 
 Inflammatory arthritis (26) 
 No hand radiographs (4) 
 Missing hand radiographic data (25) 
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Figure 2. Scatter plots showing the relation between baseline and 7-year radiographic cores, stratified by sex in the 
imputed data (n=706) 
 Females    Males 
   
  
KL, Kellgren Lawrence. Jittering has been used to allow better visualisation of overlapping markers. 
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Supplementary Table 1. Variables included in the multiple imputation model 
Concept Measurement       Baseline 7-years Included in 
subsequent 
analysis 
Descriptive & 
sociodemographic 
Sex (Female, Males)      
Age (years)      
Cohort (CASHA, CASK)      
Follow-up time (months)      
Smoking status (Never, Ex, Current)        I = 0.3%    
Index of Multiple Deprivation        I = 0.3%    
Further education (Yes, No)     
Socioeconomic status
(Office for National Statistics 2000)
     
Metabolic factors 
(2 years before 
and after 
baseline) 
BMI       I = 0.3%    
Hypertension (Present, Absent)        I = 6.5%    
Diabetes type 2 or impaired fasting glucose (Present, Absent)        I = 6.5%    
Dyslipidaemia (Present, Absent)        I = 6.5%    
No. metabolic factors (0-4)        I = 6.5%    
Metabolic Syndrome (Present, Absent) †        I = 6.5%    
No. days statins prescribed         I = 6.5%    
Radiographic OA KLsum score (0-80)   I = 45.0%   
No. joints with OA (KL≥2) (0-20)   I = 45.0%   
Hand 
characteristics 
and symptoms  
Hand problem in the past 12 months (Yes, No)      
Hand pain in the past 12 months (Yes, No)      
Side of pain in past 12 months (Right, Left, Both)      
Duration of hand problem (months)     
Duration of pain in past 12 months (<7 days, 1-4 weeks, 1-3 
months, >3 months) 
     
Frequency of pain in past 1 month (no, few, some, most, all days)      
AUSCAN pain, function & stiffness subscales
(Bellamy 2002) 
(0-20; 0-36; 
0-4 respectively) 
     
Thumb base OA (Present, Absent)       
Nodal OA (Present, Absent)       
Generalised OA (Present, Absent)       
Erosive OA (Present, Absent)       
General, physical 
and mental health 
SF12 physical and mental component scores
(Ware 1996)
 (0-100 each)     
SF36 physical functioning scale
(Ware & Sherborne 1992) 
(0-100)     
HADS anxiety and depression subscales
(Zigmond & Snaith 1983)
(0-21 each)     
Self-reported 
comorbidities and 
health problems 
Raised blood pressure (Present, Absent)      
Diabetes (Present, Absent)     
Chest problems (Present, Absent)     
Heart problems (Present, Absent)     
Deafness (Present, Absent)     
Problems with eyesight (Present, Absent)     
A fall or falls (Present, Absent)     
Difficulty remembering things (Present, Absent)     
Cough with spit (Present, Absent)     
Breathless when walking (Present, Absent)     
Dizziness or unsteadiness (Present, Absent)     
Weakness in an arm or leg (Present, Absent)     
BMI, Body Mass Index; KL, Kellgren Lawrence; AUSCAN, Australian-Canadian Hand Osteoarthritis Index; SF12, Short Form 12; HADS, Hospital Anxiety 
and Depression Scale; SF36, Short Form 36; I, Data that was imputed and the proportion. † Metabolic Syndrome = Any three of BMI≥30kg/m
2
, 
diabetes type 2/IFG, hypertension, dyslipidaemia. Thumb base OA = KL≥2 in the 1CMCJ in either hand; Nodal IPJ OA = KL≥2 in ≥2 IPJs (rays 2-5) & ≥2 
nodes (rays 2-3) across either hand; Generalised hand OA = KL≥2 in ≥1 distal IPJ & ≥1 proximal IPJ & ≥1 1CMCJ across either hand; Erosive OA = E or R 
phase in ≥2 IPJ (rays 2-5) across either hand.  
References: Bellamy N, et al. Dimensionality and clinical importance of pain and disability in hand osteoarthritis: Development of the 
Australian/Canadian (AUSCAN) Osteoarthritis Hand Index. Osteoarthritis Cartilage 2002;10:855-62. Office for National Statistics (ONS). The National 
Statistics Socioeconomic Classification User Manual (version 1). London: Office for National Statistics. 2002. Ware J Jr, et al. A 12-Item Short-Form 
Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care 1996;34:220-33. Ware JE Jr, Sherbourne CD. The MOS 
36-item Short-Form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473-83. Zigmond AS, Snaith RP. The 
hospital anxiety and depression scale. Acta Psychiatr Scand 1983;67:361-70. 
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Supplementary Figure 1. Scatter plots showing the relation between baseline and 7-year radiographic scores, 
stratified by sex in the complete case analysis (n=388) 
 Females Males 
  
  
     KL, Kellgren Lawrence. Jittering has been used to allow better visualisation of overlapping markers.  
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Supplementary Table 2. The amount of radiographic change at 7-years overall, for those free of 
radiographic OA at baseline, and also separately for baseline hand OA subsets, stratified by sex in 
the complete case analysis  
 Females    Males  
 Outcome = Kellgren-Lawrence summed score (0-80) 
 
n 
Adjusted 
mean* 
(95%CI)  n 
Adjusted 
mean* 
(95%CI) 
Total 233 16.5 (15.5, 17.5)  155 11.1 (10.0, 12.1) 
No baseline hand OA  62 5.6 (4.1, 7.2)  64 4.0 (2.5, 5.6) 
Thumb base OA 115 21.3 (19.9, 22.8)  54 16.1 (13.4, 18.9) 
Nodal IPJ OA 62 27.9 (24.2, 31.6)  23 20.7 (15.9, 25.5) 
Generalised hand OA 32 33.0 (28.5, 37.5)  13 27.2 (14.9, 39.4) 
Erosive OA 10 42.8 (38.3, 47.3)  1 - - 
 Outcome = Number of hand joints with Kellgren-Lawrence Grade≥2 (0-20) † 
 n Adjusted 
mean* (95%CI) 
 
n 
Adjusted 
mean* (95%CI) 
Total 232 6.5 (6.1, 6.9)  155 4.8 (4.3, 5.2) 
No baseline hand OA  62 2.4 (1.7, 3.0)  64 1.7 (1.0, 2.5) 
Thumb base OA 114 8.4 (7.8, 8.9)  52 6.8 (5.8, 7.7) 
Nodal IPJ OA 61 11.1 (9.9, 12.3)  23 9.2 (7.3, 11.1) 
Generalised hand OA 31 12.7 (11.2, 14.1)  13 11.0  (7.7, 14.4) 
Erosive OA 9 13.3 (11.5, 15.0)  1 - - 
95% CI, 95% Confidence interval; * adjusted for baseline value of outcome measure, cohort, age, time to follow-up; † One individual 
excluded due to maximum number of joints affected at baseline (n=20). No hand OA = KL<2 in all hand joints; Nodal IPJ OA = KL≥2 in ≥2 IPJs 
(rays 2-5) & ≥2 nodes (rays 2-3) across either hand; Thumb base OA = KL≥2 in the 1CMCJ in either hand; Generalised hand OA = KL≥2 in ≥1 
distal IPJ & ≥1 proximal IPJ & ≥1 1CMCJ across either hand; Erosive OA = ≥2 IPJ (rays 2-5) across either hand. 
 
